On Friday, Cognition Therapeutics Inc (CGTX) stock saw a modest uptick, ending the day at $0.63 which represents no change from the prior close of of $0.63. The stock opened at $0.64 and touched a low ...

"Biological ensembles use collective intelligence to tackle challenges together, but suboptimal coordination can undermine ...

Language and social cognition are fundamental to human communication. But how do these capacities interact? In a review paper ...

Researchers at the California Institute of Technology have unveiled a startling revelation about the human mind: our thoughts ...

Cognition Therapeutics (CGTX) announced topline results from the exploratory Phase 2 ‘SHIMMER’ study demonstrating CT1812 ...

Researchers have uncovered important insights that could improve how mental health conditions are treated with brain stimulation therapy -- a treatment where electrical signals are used to stimulate ...

AI isn't just changing how we think—it's dissolving the boundaries between human and machine cognition in unexpected ways.

By Vijay Kumar Malesu A recent study explores the relationship between brain connectivity and intelligence, highlighting the ...

Cognition Therapeutics' CT1812 improves dementia with Lewy bodies outcomes, reducing anxiety, hallucinations, and functional ...

Staying physically fit as you age isn't just good for your body—it's good for your mind. New research identifies 15 ways ...